82 related articles for article (PubMed ID: 12522449)
1. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
[TBL] [Abstract][Full Text] [Related]
2. The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Kchour G; Rezaee R; Farid R; Ghantous A; Rafatpanah H; Tarhini M; Kooshyar MM; El Hajj H; Berry F; Mortada M; Nasser R; Shirdel A; Dassouki Z; Ezzedine M; Rahimi H; Ghavamzadeh A; de Thé H; Hermine O; Mahmoudi M; Bazarbachi A
Retrovirology; 2013 Aug; 10():91. PubMed ID: 23962110
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
Cook LB; Rowan AG; Demontis MA; Sagawe S; Gillet NA; Melamed A; Greiller C; Witkover A; Bangham CRM; Taylor GP
Int J Hematol; 2018 Mar; 107(3):378-382. PubMed ID: 29090417
[TBL] [Abstract][Full Text] [Related]
4. Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.
Ishida T; Utsunomiya A; Jo T; Yamamoto K; Kato K; Yoshida S; Takemoto S; Suzushima H; Kobayashi Y; Imaizumi Y; Yoshimura K; Kawamura K; Takahashi T; Tobinai K; Ueda R
Cancer Sci; 2017 Oct; 108(10):2022-2029. PubMed ID: 28776876
[TBL] [Abstract][Full Text] [Related]
5. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.
Ramos JC; Ruiz P; Ratner L; Reis IM; Brites C; Pedroso C; Byrne GE; Toomey NL; Andela V; Harhaj EW; Lossos IS; Harrington WJ
Blood; 2007 Apr; 109(7):3060-8. PubMed ID: 17138822
[TBL] [Abstract][Full Text] [Related]
6. A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.
Khouri R; Silva-Santos G; Dierckx T; Menezes SM; Decanine D; Theys K; Silva AC; Farré L; Bittencourt A; Mangino M; Roederer M; Vandamme AM; Van Weyenbergh J
Oncoimmunology; 2018; 7(5):e1426423. PubMed ID: 29721391
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
Bazarbachi A; Hermine O
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S186-90. PubMed ID: 8797722
[TBL] [Abstract][Full Text] [Related]
9. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
Gill PS; Harrington W; Kaplan MH; Ribeiro RC; Bennett JM; Liebman HA; Bernstein-Singer M; Espina BM; Cabral L; Allen S
N Engl J Med; 1995 Jun; 332(26):1744-8. PubMed ID: 7760890
[TBL] [Abstract][Full Text] [Related]
10. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).
Shimoyama M
Br J Haematol; 1991 Nov; 79(3):428-37. PubMed ID: 1751370
[TBL] [Abstract][Full Text] [Related]
12. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Tsukasaki K; Utsunomiya A; Fukuda H; Shibata T; Fukushima T; Takatsuka Y; Ikeda S; Masuda M; Nagoshi H; Ueda R; Tamura K; Sano M; Momita S; Yamaguchi K; Kawano F; Hanada S; Tobinai K; Shimoyama M; Hotta T; Tomonaga M;
J Clin Oncol; 2007 Dec; 25(34):5458-64. PubMed ID: 17968021
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
[TBL] [Abstract][Full Text] [Related]
14. Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.
Sharma K; Janik JE; O'Mahony D; Stewart D; Pittaluga S; Stetler-Stevenson M; Jaffe ES; Raffeld M; Fleisher TA; Lee CC; Steinberg SM; Waldmann TA; Morris JC
Clin Cancer Res; 2017 Jan; 23(1):35-42. PubMed ID: 27486175
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
[TBL] [Abstract][Full Text] [Related]
16. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.
Ratner L; Harrington W; Feng X; Grant C; Jacobson S; Noy A; Sparano J; Lee J; Ambinder R; Campbell N; Lairmore M;
PLoS One; 2009; 4(2):e4420. PubMed ID: 19204798
[TBL] [Abstract][Full Text] [Related]
17. Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
Besson C; Panelatti G; Delaunay C; Gonin C; Brebion A; Hermine O; Plumelle Y
Leuk Lymphoma; 2002 Dec; 43(12):2275-9. PubMed ID: 12613513
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.
Letafati A; Soheili R; Norouzi M; Soleimani P; Mozhgani SH
Med Oncol; 2023 Sep; 40(10):295. PubMed ID: 37689806
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions.
Stuver R; Horwitz SM; Epstein-Peterson ZD
Curr Treat Options Oncol; 2023 Aug; 24(8):948-964. PubMed ID: 37300656
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
